Hereditary hemochromatosis affects how the body handles iron. A genetic result can help explain why someone absorbs too much, but understanding that result also requires information about iron levels and health. This evergreen explainer focuses on HFE-related hemochromatosis, the most common hereditary form.
Why iron can become a problem
Iron is essential: the body uses it to make hemoglobin, which carries oxygen in red blood cells. Iron tests measure several aspects of its supply, transport and storage. Both too little and too much can cause health problems. MedlinePlus explains these different measurements.
In hereditary hemochromatosis, altered regulation allows excessive iron absorption from food. Iron can accumulate in organs and joints, eventually damaging them. Symptoms may include tiredness, joint pain or abdominal discomfort, but these symptoms have many possible explanations. Their presence alone cannot identify an inherited iron disorder. MedlinePlus Genetics describes the condition and its causes.
What an HFE result establishes
A common HFE variant is called p.Cys282Tyr, also known as C282Y. Having this variant in both gene copies is the main genetic finding associated with HFE-related hemochromatosis. However, many people with that combination never develop organ damage from iron overload. Other common HFE combinations have substantially lower clinical penetrance, meaning fewer people develop disease. GeneReviews explains these differences.
It therefore helps to keep three questions separate: What genetic combination is present? Is there biochemical evidence of excess iron? Has iron caused organ damage? A report answering the first question does not automatically answer the others.
Why several blood measurements matter
Serum iron measures iron circulating in blood. Transferrin is a protein that transports it, while total iron-binding capacity describes the blood’s capacity to bind iron. Ferritin helps assess stored iron. These measurements provide different pieces of information rather than interchangeable answers. See the MedlinePlus guide to iron tests.
Blood iron varies during the day, and medicines and other circumstances can affect results. Interpretation takes account of medical history, symptoms and other tests. An abnormal result does not necessarily mean a condition requires treatment. This is why a highlighted laboratory number needs context.
Ferritin deserves particular care: it can rise with inflammation or liver disorders even without iron overload. Clinicians interpret it alongside transferrin saturation and the wider assessment. GeneReviews discusses this diagnostic limitation.
Inheritance depends on the cause
HFE-related hemochromatosis follows autosomal recessive inheritance. Usually, each parent contributes one altered gene copy. A parent carrying one copy may have no symptoms, so a family can have an inherited condition without an obvious history of illness.
Hemochromatosis also has other genetic causes. HJV, HAMP and TFR2 are associated with recessively inherited forms, while SLC40A1-related disease can follow dominant inheritance. Some forms begin much earlier than typical HFE-related disease. The exact gene matters when discussing relatives and family probabilities. MedlinePlus Genetics outlines these distinctions.
Established care and the limits of evidence
For people who need iron removal, therapeutic phlebotomy—controlled removal of blood—is established treatment. Follow-up blood measurements guide its use. Care also addresses any liver, heart, hormonal or joint complications. Early recognition can help prevent serious damage, although existing damage may not fully reverse. The MedlinePlus medical encyclopedia describes assessment and treatment.
Iron overload can also occur through other routes, including repeated blood transfusions. Assessment may therefore include other explanations and, where appropriate, imaging or additional organ tests. An HFE result should be interpreted within that broader picture.
Research continues to examine why people with the same HFE combination have different outcomes. Uncertainty also remains about the long-term benefits of iron removal in some people with only mildly elevated ferritin. Established treatment for clinically important overload and evidence about these milder situations should be discussed separately. GeneReviews reviews the evidence gaps.